Sequence-Specific Features of Short Double-Strand, Blunt-End RNAs Have RIG-I- and Type 1 Interferon-Dependent or -Independent Anti-Viral Effects.
Abhilash KannanMaarit SuomalainenRomain VolleMichael BauerMarco AmslerHung V TrinhStefano VavassoriJana Pachlopnik SchmidGuilherme VilhenaAlberto Marín-GonzálezRubén PérezAndrea FranceschiniChristian von MeringSilvio HemmiUrs F GreberPublished in: Viruses (2022)
Pathogen-associated molecular patterns, including cytoplasmic DNA and double-strand (ds)RNA trigger the induction of interferon (IFN) and antiviral states protecting cells and organisms from pathogens. Here we discovered that the transfection of human airway cell lines or non-transformed fibroblasts with 24mer dsRNA mimicking the cellular micro-RNA (miR)29b-1* gives strong anti-viral effects against human adenovirus type 5 (AdV-C5), influenza A virus X31 (H3N2), and SARS-CoV-2. These anti-viral effects required blunt-end complementary RNA strands and were not elicited by corresponding single-strand RNAs. dsRNA miR-29b-1* but not randomized miR-29b-1* mimics induced IFN-stimulated gene expression, and downregulated cell adhesion and cell cycle genes, as indicated by transcriptomics and IFN-I responsive Mx1-promoter activity assays. The inhibition of AdV-C5 infection with miR-29b-1* mimic depended on the IFN-alpha receptor 2 (IFNAR2) and the RNA-helicase retinoic acid-inducible gene I (RIG-I) but not cytoplasmic RNA sensors MDA5 and ZNFX1 or MyD88/TRIF adaptors. The antiviral effects of miR29b-1* were independent of a central AUAU-motif inducing dsRNA bending, as mimics with disrupted AUAU-motif were anti-viral in normal but not RIG-I knock-out (KO) or IFNAR2-KO cells. The screening of a library of scrambled short dsRNA sequences identified also anti-viral mimics functioning independently of RIG-I and IFNAR2, thus exemplifying the diverse anti-viral mechanisms of short blunt-end dsRNAs.
Keyphrases
- sars cov
- gene expression
- cell cycle
- dendritic cells
- endothelial cells
- induced apoptosis
- immune response
- cell cycle arrest
- respiratory syndrome coronavirus
- dna methylation
- cell adhesion
- cell proliferation
- open label
- inflammatory response
- high glucose
- coronavirus disease
- clinical trial
- oxidative stress
- multidrug resistant
- copy number
- randomized controlled trial
- gram negative
- phase ii
- cancer therapy
- pluripotent stem cells
- drug delivery
- genome wide identification
- genetic diversity